Forbes - Markets
MannKind And Afrezza: Can The Drug Cure The Company?
I like the drug Afrezza, I am not a MannKind bull and I don’t much like how the company is being run. Maybe that will change when/if Afrezza sales pick up, but predicting that is beyond my area of expertise.
No comments:
Post a Comment